Molecular Biology, Diagnosis and Management of Thyroid Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 1 May 2024 | Viewed by 1163
Special Issue Editor
Interests: thyroid cancer; oncogenes; cell signaling; liquid biopsy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thyroid cancer is a growing health concern in the U.S. and other countries, with increasing incidence rates over the last 40 years. To improve the diagnosis and treatment of this disease, it is essential to understand the molecular mechanisms that regulate thyroid cancer development and metastatic progression. Genomic profiling of thyroid tumors using next-generation sequencing (NGS) and other molecular methods can help to provide more accurate diagnoses and personalized treatment plans. Additionally, the detection of genomic alterations in cell-free DNA and tumor-specific biomarkers in the blood of thyroid cancer patients can be useful for monitoring therapeutic response and detecting recurrence or metastasis. We welcome manuscripts that address emerging challenges in molecular diagnosis and therapy of thyroid cancer patients, including, but not limited to the following topics:
- Exosomes in thyroid cancer;
- Extrachromosomal circular DNA in thyroid cancer;
- Crosstalk between cell signaling and miRNA in thyroid cancer;
- Liquid biopsy for thyroid cancer diagnoses;
- Thyroid cancer metabolomics;
- Sex-specific molecular determinant of thyroid cancer;
- Patient-derived xenograft (PDX) models for personalized treatment in thyroid cancer.
Dr. Vasko Vasyl
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid
- cancer
- liquid biopsy
- cell-free DNA
- exosomes
- metabolomic
- microRNA
